These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12429716

  • 1. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2.
    Namba K, Kitaichi N, Nishida T, Taylor AW.
    J Leukoc Biol; 2002 Nov; 72(5):946-52. PubMed ID: 12429716
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH).
    Taylor A, Namba K.
    Immunol Cell Biol; 2001 Aug; 79(4):358-67. PubMed ID: 11488983
    [Abstract] [Full Text] [Related]

  • 4. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis.
    Yotsukura J, Huang H, Singh AK, Shichi H.
    Cell Immunol; 1997 Dec 15; 182(2):89-98. PubMed ID: 9514702
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC, Hay V, Cheever AW, Mamura M, Sher A, Letterio JJ, Shevach EM, Piccirillo CA.
    Eur J Immunol; 2005 Oct 15; 35(10):2886-95. PubMed ID: 16180248
    [Abstract] [Full Text] [Related]

  • 7. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
    Laliotou B, Duncan L, Dick AD.
    J Autoimmun; 1999 May 15; 12(3):145-55. PubMed ID: 10222024
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice.
    Rizzo LV, Silver P, Wiggert B, Hakim F, Gazzinelli RT, Chan CC, Caspi RR.
    J Immunol; 1996 Feb 15; 156(4):1654-60. PubMed ID: 8568272
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis.
    Agarwal RK, Chan CC, Wiggert B, Caspi RR.
    J Immunol; 1999 Mar 01; 162(5):2648-54. PubMed ID: 10072507
    [Abstract] [Full Text] [Related]

  • 12. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
    Taylor AW, Kitaichi N.
    Brain Behav Immun; 2008 Jul 01; 22(5):639-46. PubMed ID: 18171609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A, Usui Y, Takeuchi M, Hattori T, Kezuka T, Suzuki J, Okunuki Y, Iwasaki T, Haino M, Matsushima K, Usui M.
    Invest Ophthalmol Vis Sci; 2005 Oct 01; 46(10):3753-60. PubMed ID: 16186359
    [Abstract] [Full Text] [Related]

  • 16. Thrombospondin plays a vital role in the immune privilege of the eye.
    Zamiri P, Masli S, Kitaichi N, Taylor AW, Streilein JW.
    Invest Ophthalmol Vis Sci; 2005 Mar 01; 46(3):908-19. PubMed ID: 15728547
    [Abstract] [Full Text] [Related]

  • 17. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.
    Kerr EC, Raveney BJ, Copland DA, Dick AD, Nicholson LB.
    J Autoimmun; 2008 Dec 01; 31(4):354-61. PubMed ID: 18838247
    [Abstract] [Full Text] [Related]

  • 18. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
    Horwitz DA, Zheng SG, Gray JD, Wang JH, Ohtsuka K, Yamagiwa S.
    Semin Immunol; 2004 Apr 01; 16(2):135-43. PubMed ID: 15036237
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I, König B, Böttcher I, Knop J, Saloga J.
    Clin Exp Allergy; 2006 Dec 01; 36(12):1546-55. PubMed ID: 17177678
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.